Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 7Endometrial Neoplasms 4Lymphedema 3Neoplasms 2Melanoma 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Suspected Central Nervous System Tumors 1Stomach Neoplasms 1Skull Base Neoplasms 1Pediatric Patients With Solid Tumors 1Mixed Tumor, Mesodermal 1Lung Neoplasms 1Head and Neck Neoplasms 1Gastrointestinal Stromal Tumors 1Gastrointestinal Diseases 1Colorectal Neoplasms 1Colonic Neoplasms 1Cholecystitis 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 106Pemetrexed 74Paclitaxel 58Cisplatin 52Erlotinib Hydrochloride 51Radiotherapy 49Docetaxel 43Gemcitabine 41Bevacizumab 41pembrolizumab 30Nivolumab 25Radiosurgery 21Etoposide 20durvalumab 13Cetuximab 13Specimen Handling 12Ipilimumab 12Magnetic Resonance Spectroscopy 11Gefitinib 11Vinorelbine 10Taxes 10Radiation 10Albumin-Bound Paclitaxel 10osimertinib 9Biopsy 9vandetanib 8Topotecan 7Platinum 7Irinotecan 7Drug Therapy 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Lung Neoplasms × Indocyanine Green × Clear all
NCT00540982 2025-07-02

Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction

City of Hope Medical Center

Phase 1/2 Completed
47 enrolled 7 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡